10-Q Filing

GUIDED THERAPEUTICS INC CIK: 924515 Q1 2017

Filing Information

Form Type	10-Q
Accession Number	`0001121781-17-000030`
Period End Date	20170331
Filing Date	20170522
Fiscal Year	2017
Fiscal Period	Q1
XBRL Instance	gthp-20170331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 88 Income Statement 38 Cash Flow Statement 54

Balance Sheet 88 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$56.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$14.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.00K	USD	Point-in-time
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$244.00K	USD	Point-in-time
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$279.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$35.00K	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$279.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $244 and $279 at March 31, 2017 and December 31, 2016, respectively	`AccountsReceivableNet`	-	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$278.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $244 and $279 at March 31, 2017 and December 31, 2016, respectively	`AccountsReceivableNet`	$41.00K	USD	Point-in-time
Inventory, net of reserves of $279 and $278, at March 31, 2017 and December 31, 2016, respectively	`InventoryNet`	$773.00K	USD	Point-in-time
Inventory, net of reserves of $279 and $278, at March 31, 2017 and December 31, 2016, respectively	`InventoryNet`	$836.00K	USD	Point-in-time
Series C convertible preferred stock par value	`PreferredStockParOrStatedValuePerShareSeriesC`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$259.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$206.00K	USD	Point-in-time
Series C convertible preferred stock par value	`PreferredStockParOrStatedValuePerShareSeriesC`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.05M	USD	Point-in-time
Series C convertible preferred stock shares authorized	`PreferredStockSharesAuthorizedSeriesC`	9.00	shares	Point-in-time
Series C convertible preferred stock shares authorized	`PreferredStockSharesAuthorizedSeriesC`	9.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.08M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$126.00K	USD	Point-in-time
Series C convertible preferred stock, Issued	`PreferredStockSharesIssuedSeriesC`	1.60	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$89.00K	USD	Point-in-time
Series C convertible preferred stock, Issued	`PreferredStockSharesIssuedSeriesC`	1.40	shares	Point-in-time
Series C convertible preferred stock, Outstanding	`PreferredStockSharesOutstandingSeriesC`	1.60	shares	Point-in-time
Other assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$320.00K	USD	Point-in-time
Series C convertible preferred stock, Outstanding	`PreferredStockSharesOutstandingSeriesC`	1.40	shares	Point-in-time
Other assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$319.00K	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$446.00K	USD	Point-in-time
Series C convertible preferred stock, Liquidation preference	`PreferredStockLiquidationPreference`	$1.41K	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$408.00K	USD	Point-in-time
Series C convertible preferred stock, Liquidation preference	`PreferredStockLiquidationPreference`	$1.64K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$1.49M	USD	Point-in-time
Series C1 convertible preferred stock par value	`PreferredStockParOrStatedValuePerShareSeriesC1`	$0.00	USD	Point-in-time
Series C1 convertible preferred stock par value	`PreferredStockParOrStatedValuePerShareSeriesC1`	$0.00	USD	Point-in-time
TOTAL ASSETS	`Assets`	$1.49M	USD	Point-in-time
Series C1 convertible preferred stock shares authorized	`PreferredStockSharesAuthorizedSeriesC1`	20.30	shares	Point-in-time
Series C1 convertible preferred stock shares authorized	`PreferredStockSharesAuthorizedSeriesC1`	20.30	shares	Point-in-time
Note payable in default, including related parties	`NotePayableInDefault`	$1.01M	USD	Point-in-time
Note payable in default, including related parties	`NotePayableInDefault`	$651.00K	USD	Point-in-time
Series C1 convertible preferred stock, Issued	`PreferredStockSharesIssuedSeriesC1`	4.30	shares	Point-in-time
Series C1 convertible preferred stock, Issued	`PreferredStockSharesIssuedSeriesC1`	4.30	shares	Point-in-time
Short-term notes payable, including related parties	`ShorttermNotesPayable`	$197.00K	USD	Point-in-time
Series C1 convertible preferred stock, Outstanding	`PreferredStockSharesOutstandingSeriesC1`	4.30	shares	Point-in-time
Short-term notes payable, including related parties	`ShorttermNotesPayable`	$599.00K	USD	Point-in-time
Series C1 convertible preferred stock, Outstanding	`PreferredStockSharesOutstandingSeriesC1`	4.30	shares	Point-in-time
Series C1 convertible preferred stock, Liquidation preference	`PreferredStockLiquidationPreferenceC1`	$4.31K	USD	Point-in-time
Convertible note in default	`ConvertibleNotesPayableCurrent`	$2.36M	USD	Point-in-time
Series C1 convertible preferred stock, Liquidation preference	`PreferredStockLiquidationPreferenceC1`	$4.31K	USD	Point-in-time
Convertible note in default	`ConvertibleNotesPayableCurrent`	$2.35M	USD	Point-in-time
Short-term convertible notes payable, net	`NotesAndLoansPayableCurrent`	$468.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Short-term convertible notes payable, net	`NotesAndLoansPayableCurrent`	$595.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, Authorized	`CommonStockSharesAuthorized`	1.00M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.60M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.75M	USD	Point-in-time
Common stock, Authorized	`CommonStockSharesAuthorized`	1.00M	shares	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$2.67M	USD	Point-in-time
Common stock, Issued	`CommonStockSharesIssued`	1,427.00	shares	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$2.72M	USD	Point-in-time
Common stock, Issued	`CommonStockSharesIssued`	669.00	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	669.00	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	1,427.00	shares	Point-in-time
Deferred revenue	`DeferredRevenue`	$34.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$30.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$9.34M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$9.70M	USD	Point-in-time
Warrants, at fair value	`WarrantsNotSettleableInCashFairValueDisclosure`	$847.00K	USD	Point-in-time
Warrants, at fair value	`WarrantsNotSettleableInCashFairValueDisclosure`	$1.42M	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$10.76M	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$10.54M	USD	Point-in-time
Series C convertible preferred stock, $.001 par value; 9.0 shares authorized, 1.4 and 1.6 shares issued and outstanding as of March 31, 2017 and December 31, 2016, (Liquidation preference of $1,406 and $1,643 at March 31, 2017 and December 31, 2016)	`SeriesCPreferredStock`	$514.00K	USD	Point-in-time
Series C convertible preferred stock, $.001 par value; 9.0 shares authorized, 1.4 and 1.6 shares issued and outstanding as of March 31, 2017 and December 31, 2016, (Liquidation preference of $1,406 and $1,643 at March 31, 2017 and December 31, 2016)	`SeriesCPreferredStock`	$601.00K	USD	Point-in-time
Series C1 convertible preferred stock, $.001 par value; 20.3 shares authorized, 4.3 shares issued and outstanding as of March 31, 2017 and December 31, 2016, respectively (Liquidation preference of $4,312 at March 31, 2017 and December 31, 2016, respectively)	`ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue`	$701.00K	USD	Point-in-time
Series C1 convertible preferred stock, $.001 par value; 20.3 shares authorized, 4.3 shares issued and outstanding as of March 31, 2017 and December 31, 2016, respectively (Liquidation preference of $4,312 at March 31, 2017 and December 31, 2016, respectively)	`ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue`	$701.00K	USD	Point-in-time
Common stock, $.001 Par value; 1,000,000 shares authorized, 1,427 and 669 shares issued and outstanding as of March, 31 2017 and December 31, 2016	`CommonStockValue`	$742.00K	USD	Point-in-time
Common stock, $.001 Par value; 1,000,000 shares authorized, 1,427 and 669 shares issued and outstanding as of March, 31 2017 and December 31, 2016	`CommonStockValue`	$743.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$116.38M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$116.89M	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$132.00K	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$132.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-127.56M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-127.76M	USD	Point-in-time
TOTAL STOCKHOLDERS' DEFICIT	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-9.05M	USD	Point-in-time
TOTAL STOCKHOLDERS' DEFICIT	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-9.27M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$1.49M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$1.49M	USD	Point-in-time

Income Statement 38 line items

Line Item	Tag	Value	Unit	Period
Sales - devices and disposables	`SalesDevicesAndDisposables`	$21.00K	USD	1 Quarter
Sales - devices and disposables	`SalesDevicesAndDisposables`	$262.00K	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	$16.00K	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	$68.00K	USD	1 Quarter
Gross profit	`GrossProfit`	$194.00K	USD	1 Quarter
Gross profit	`GrossProfit`	$5.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$290.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$91.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$82.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$117.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$917.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$346.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.32M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$519.00K	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-1.13M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-514.00K	USD	1 Quarter
Other income	`OtherIncome`	$2.00K	USD	1 Quarter
Other income	`OtherIncome`	$23.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$158.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$223.00K	USD	1 Quarter
Changes in fair value of warrants	`DerivativeGainLossOnDerivativeNet`	$628.00K	USD	1 Quarter
Changes in fair value of warrants	`DerivativeGainLossOnDerivativeNet`	$1.40M	USD	1 Quarter
Total other income	`OtherNonoperatingIncomeExpense`	$407.00K	USD	1 Quarter
Total other income	`OtherNonoperatingIncomeExpense`	$1.26M	USD	1 Quarter
(LOSS) INCOME FROM OPERATIONS	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-107.00K	USD	1 Quarter
(LOSS) INCOME FROM OPERATIONS	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$130.00K	USD	1 Quarter
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	1 Quarter
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	1 Quarter
NET (LOSS) INCOME	`NetIncomeLoss`	$130.00K	USD	1 Quarter
NET (LOSS) INCOME	`NetIncomeLoss`	$-107.00K	USD	1 Quarter
PREFERRED STOCK DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	$470.00K	USD	1 Quarter
PREFERRED STOCK DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	$99.00K	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-206.00K	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-340.00K	USD	1 Quarter
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-0.22	USD	1 Quarter
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-0.11	USD	1 Quarter
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	39.00	shares	1 Quarter
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	946.00	shares	1 Quarter

Cash Flow Statement 54 line items

Line Item	Tag	Value	Unit	Period
Net (loss) income	`NetIncomeLoss`	$130.00K	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-107.00K	USD	1 Quarter
Bad debt expense	`BadDebtExpense`	$17.00K	USD	1 Quarter
Bad debt expense	`BadDebtExpense`	$-35.00K	USD	1 Quarter
Depreciation	`DepreciationDepletionAndAmortization`	$54.00K	USD	1 Quarter
Depreciation	`DepreciationDepletionAndAmortization`	$37.00K	USD	1 Quarter
Amortization	`AdjustmentForAmortization`	$54.00K	USD	1 Quarter
Amortization	`AdjustmentForAmortization`	-	USD	1 Quarter
Stock based compensation	`ShareBasedCompensation`	$19.00K	USD	1 Quarter
Stock based compensation	`ShareBasedCompensation`	$30.00K	USD	1 Quarter
Change in fair value of warrants	`ChangeInFairValueOfWarrants`	$1.40M	USD	1 Quarter
Change in fair value of warrants	`ChangeInFairValueOfWarrants`	$628.00K	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	$135.00K	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	$63.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$56.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$6.00K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-52.00K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-271.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-1.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-18.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$153.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$148.00K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-151.00K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-4.00K	USD	1 Quarter
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$179.00K	USD	1 Quarter
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$55.00K	USD	1 Quarter
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$-300.00K	USD	1 Quarter
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$-1.08M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInContinuingOperations`	$-407.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInContinuingOperations`	$-955.00K	USD	1 Quarter
Net proceeds from issuance of common stock and warrants, net	`ProceedsFromRepurchaseOfEquity`	-	USD	1 Quarter
Net proceeds from issuance of common stock and warrants, net	`ProceedsFromRepurchaseOfEquity`	$217.00K	USD	1 Quarter
Proceeds from debt financing, net of discounts and debt issuance costs	`ProceedsFromIssuanceOfLongTermDebt`	$212.00K	USD	1 Quarter
Proceeds from debt financing, net of discounts and debt issuance costs	`ProceedsFromIssuanceOfLongTermDebt`	$1.03M	USD	1 Quarter
Payments on notes payable	`PaymentsOfLoanCosts`	$35.00K	USD	1 Quarter
Payments on notes payable	`PaymentsOfLoanCosts`	$53.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$394.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$976.00K	USD	1 Quarter
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$21.00K	USD	1 Quarter
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-13.00K	USD	1 Quarter
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$56.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$14.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$1.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$35.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$56.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$14.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$35.00K	USD	Point-in-time
Cash paid for Interest	`InterestPaid`	$1.00K	USD	1 Quarter
Cash paid for Interest	`InterestPaid`	$1.00K	USD	1 Quarter
Issuance of common stock as debt repayment	`IssuanceOfCommonStockAsDebtRepayment`	$17.00K	USD	1 Quarter
Issuance of common stock as debt repayment	`IssuanceOfCommonStockAsDebtRepayment`	$125.00K	USD	1 Quarter
Dividends on preferred stock	`DividendsOnPreferredStock`	$99.00K	USD	1 Quarter
Dividends on preferred stock	`DividendsOnPreferredStock`	$470.00K	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.